UT Researcher Added to Suspicious Behavior List

Here is an item from the Wall Street Journal about another researcher at a major university who did not disclosure significant payments from a pharma company:


Karen Wagner, a child psychiatrist at the University of Texas Medical Branch, is the latest academic psychiatrist to be criticized by Sen. Chuck Grassley (R-Iowa) for failing to fully disclose drug industry ties.

Grassley said in a letter that Wagner didn't disclose more than $150,000 in consulting and speaking fees she received from GlaxoSmithKline in recent years, the WSJ reports. Wagner worked on an NIH study of the treatment of teenage depression that included Glaxo's antidepressant Paxil. Wagner didn't respond to the WSJ's requests for comment. The university said it would look into the alleged discrepancies.

CLICK LINK FOR MUCH MORE

http://blogs.wsj.com/health/2008/09/11/sen-grassley-blasts-psychiatrist-for-failure-to-disclose-industry-funding/

http://snipurl.com/3pde2

Paxil on Trial

I am going to check into this book, found a reference to it on the pharmalot blog.

"Alison Bass has put on trial in her book far more than just a bestselling antidepressant--she has used the case of Paxil to expose the unsavory and self-serving relationships among members of the pharmaceutical industry, psychiatrists, and members of the FDA. And she does it in a book that has the brio of a crime thriller...." -The New England Journal of Medicine

http://www.alison-bass.com/


Here is another current tidbit related to the antidepressant, Paxil and unsavory behavior.

Among the 30 or so physicians at two dozen universities that the Senate Finance Committee is probing concerning disclosure of grants from drugmakers is Martin Keller, a psychiatrist at Brown University who is a controversial figure for his role in studying Glaxo's Paxil antidepressant. The committee, according to sources familiar with the investigation, sent a letter to Brown as part of its investigation. We are awaiting a reply from Brown and will update you shortly.

http://www.pharmalot.com/2008/07/grassley-targets-browns-keller-over-grants/

http://snipurl.com/2zgd1